麻豆传媒

Reduced toxicity and improved convenience position new treatments for broader use

Experts at ASH debate quadruplet therapy, dexamethasone modulation, and novel approaches

Phase III trial sparks discussion on defining and managing high-risk smoldering myeloma

Vinay Prasad, MD, leads the roundtable discussion with Aaron Goodman, MD, and Manni Mohyuddin, MD

Vinay Prasad, MD, discusses the GMMG-HD7 trial with Aaron Goodman, MD, and Manni Mohyuddin, MD

Vinay Prasad, MD, leads a roundtable discussion with Aaron Goodman, MD, and Manni Mohyuddin, MD

Vinay Prasad, MD, leads a roundtable discussion with Aaron Goodman, MD, and Manni Mohyuddin, MD

Whether curative, accessibility concerns, and timing of treatment still need to be answered

How much treatment is too much for newly diagnosed patients?

Vinay Prasad, MD, leads roundtable discussion with Aaron Goodman, MD, and Al-Ola Abdallah, MD

Vinay Prasad, MD, leads the roundtable discussion with Aaron Goodman, MD, and Al-Ola Abdallah, MD

Vinay Prasad, MD, leads the roundtable discussion with Aaron Goodman, MD, and Al-Ola Abdallah, MD